These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
419 related articles for article (PubMed ID: 2525826)
21. Atrial natriuretic peptide receptors in renal papilla of DOCA-salt hypertensive rats. Nuglozeh E; Gauquelin G; Garcia R; Tremblay J; Schiffrin EL Am J Physiol; 1990 Jul; 259(1 Pt 2):F130-7. PubMed ID: 2165357 [TBL] [Abstract][Full Text] [Related]
22. Variable renal atrial natriuretic factor gene expression in hypertension. Ogawa T; Linz W; Schölkens BA; de Bold AJ Hypertension; 1999 Jun; 33(6):1342-7. PubMed ID: 10373213 [TBL] [Abstract][Full Text] [Related]
23. Increased sensitivity to norepinephrine cardiac arrhythmias in the deoxycorticosterone acetate high salt rat before the onset of hypertension. Rabkin SW; Fung AY Can J Physiol Pharmacol; 1984 Jun; 62(6):605-9. PubMed ID: 6744105 [TBL] [Abstract][Full Text] [Related]
24. Pathophysiological role of augmented atrial natriuretic polypeptide gene expression in DOCA-salt hypertension. Effects of atrial natriuretic polypeptide monoclonal antibody. Itoh H; Nakao K; Mukoyama M; Arai H; Yamada T; Saito Y; Shiono S; Hosoda K; Shirakami G; Suga S Am J Hypertens; 1991 Jan; 4(1 Pt 1):39-44. PubMed ID: 1706603 [TBL] [Abstract][Full Text] [Related]
26. Naloxone attenuates development of hypertension in DOCA-salt hypertensive rats. Zhai SD; Malvin RL Clin Exp Hypertens A; 1991; 13(1):133-42. PubMed ID: 2022070 [TBL] [Abstract][Full Text] [Related]
27. Diuretic, natriuretic and hypotensive effects of synthetic atrial natriuretic factor in conscious newborn calves. Amadieu M; Giry J; Barlet JP J Dev Physiol; 1988 Feb; 10(1):37-45. PubMed ID: 2965177 [TBL] [Abstract][Full Text] [Related]
28. Role of renal nerves in the hypotensive and the renal effects of atrial natriuretic factor in rats. Kau MM; Wu JN; Huang WC Chin J Physiol; 1990; 33(1):5-18. PubMed ID: 2142916 [TBL] [Abstract][Full Text] [Related]
30. Changes in blood pressure and extracellular fluid with taurine in DOCA-salt rats. Fujita T; Sato Y Am J Physiol; 1986 Jun; 250(6 Pt 2):R1014-20. PubMed ID: 3717374 [TBL] [Abstract][Full Text] [Related]
31. Mechanisms underlying the augmented responses of deoxycorticosterone acetate-salt hypertensive rats to neutral endopeptidase inhibitors. Hirata Y; Suzuki Y; Suzuki E; Hayakawa H; Kimura K; Goto A; Omata M; Minamino N; Kangawa K; Matsuo H J Hypertens; 1994 Apr; 12(4):367-74. PubMed ID: 8064160 [TBL] [Abstract][Full Text] [Related]
32. Endothelin-A receptor blockade prevents left ventricular hypertrophy and dysfunction in salt-sensitive experimental hypertension. Rothermund L; Vetter R; Dieterich M; Kossmehl P; Gögebakan O; Yagil C; Yagil Y; Kreutz R Circulation; 2002 Oct; 106(18):2305-8. PubMed ID: 12403658 [TBL] [Abstract][Full Text] [Related]
33. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats. Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584 [TBL] [Abstract][Full Text] [Related]
34. Renal dopamine not renal nerve mediates diuretic and natriuretic effect of ANF in rats. Kau MM; Huang WC Chin J Physiol; 1991; 34(3):317-31. PubMed ID: 1839729 [TBL] [Abstract][Full Text] [Related]
35. Effect of chronic treatment with deoxycorticosterone acetate on content of a natriuretic substance in atria of rats. Hathaway SJ; Fregly MJ; Wilson KM; Papanek PE; Henley WN Proc Soc Exp Biol Med; 1986 Oct; 183(1):92-8. PubMed ID: 2944121 [TBL] [Abstract][Full Text] [Related]
36. Natriuretic peptide gene expression in DOCA-salt hypertension after blockade of type B endothelin receptor. Bianciotti LG; de Bold AJ Am J Physiol Heart Circ Physiol; 2002 Mar; 282(3):H1127-34. PubMed ID: 11834512 [TBL] [Abstract][Full Text] [Related]
37. Renal and depressor effects of SQ 29,072, a neutral endopeptidase inhibitor, in conscious hypertensive rats. Seymour AA; Norman JA; Asaad MM; Fennell SA; Swerdel JN; Little DK; Dorso CR J Cardiovasc Pharmacol; 1990 Jul; 16(1):163-72. PubMed ID: 1696660 [TBL] [Abstract][Full Text] [Related]
38. 5-Carboxamidotryptamine attenuates the development of deoxycorticosterone acetate-salt hypertension in rats. Balasubramaniam G; Lee HS; Mah SC Eur J Pharmacol; 1995 Mar; 276(1-2):183-90. PubMed ID: 7781688 [TBL] [Abstract][Full Text] [Related]
39. Effects of chronically administered atrial natriuretic factor in aldosterone-infused hypertensive rats. Yasujima M; Abe K; Kanazawa M; Kohzuki M; Yoshida K; Hiwatari M; Saito T; Saso S; Yoshinaga K Jpn Circ J; 1988 Dec; 52(12):1446-9. PubMed ID: 2977195 [TBL] [Abstract][Full Text] [Related]
40. Phasic plasma atrial natriuretic polypeptide changes in DOCA-salt hypertensive rats. Sato Y; Ito Y; Ando K; Ogata E; Fujita T Jpn Heart J; 1990 Sep; 31(5):703-11. PubMed ID: 2148777 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]